← Eichor
Study identifier: NCT05847010 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Accompanying Scientific Program for the Quality Contract Prevention of Postoperative Delirium in the Care of Older Patients (WB-QC-POD)

Condition: Postoperative Delirium  ·  Sponsor: Charite University, Berlin, Germany

PhaseN/A
Planned participants100
Who can joinAll sexes, 70 Years to no upper limit
Healthy volunteersNo

About this study

In the course of a scientific accompanying program, the project pursues the goal of gaining further insight into a possible connection between various influencing factors and the development of postoperative delirium. Against this background, in addition to the primary goal of exploring delirium rates, we aim to identify associations between other secondary end goals like the internal circadian time or the heart rate variability and the occurrence of postoperative delirium. For this purpose, patients of the QC-POD (NCT04355195) sample will be studied.

This description comes directly from the study's public registry record.

Talk to the study team

Claudia Spies, MD, Prof.  ·  +49 30 450 55 11 02  ·  claudia.spies@charite.de

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Anaesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum (CVK) and Campus Charite Mitte (CCM), Charite - Universitätsmedizin BerlinBerlin, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05847010